BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14656116)

  • 21. "Clicktophycin-52": a bioactive cryptophycin-52 triazole analogue.
    Nahrwold M; Bogner T; Eissler S; Verma S; Sewald N
    Org Lett; 2010 Mar; 12(5):1064-7. PubMed ID: 20131817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of cryptophycin 52 using the Shi epoxidation.
    Hoard DW; Moher ED; Martinelli MJ; Norman BH
    Org Lett; 2002 May; 4(10):1813-5. PubMed ID: 12000306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enantioselective organocatalytic approach to alpha-methylene-delta-lactones and delta-lactams.
    Albrecht Ł; Richter B; Krawczyk H; Jørgensen KA
    J Org Chem; 2008 Nov; 73(21):8337-43. PubMed ID: 18831593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
    Al-Awar RS; Corbett TH; Ray JE; Polin L; Kennedy JH; Wagner MM; Williams DC
    Mol Cancer Ther; 2004 Sep; 3(9):1061-7. PubMed ID: 15367700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of the antitumor compound cryptophycin-52 with tubulin.
    Panda D; Ananthnarayan V; Larson G; Shih C; Jordan MA; Wilson L
    Biochemistry; 2000 Nov; 39(46):14121-7. PubMed ID: 11087360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An efficient approach to trans-4-hydroxy-5-substituted 2-pyrrolidinones through a stereoselective tandem Barbier process: divergent syntheses of (3R,4S)-statines, (+)-preussin and (-)-hapalosin.
    Si CM; Shao LP; Mao ZY; Zhou W; Wei BG
    Org Biomol Chem; 2017 Jan; 15(3):649-661. PubMed ID: 27973631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A convergent synthesis of (+)-cryptophycin B, a potent antitumor macrolide from Nostoc sp. cyanobacteria.
    Ghosh AK; Bischoff A
    Org Lett; 2000 Jun; 2(11):1573-5. PubMed ID: 10841482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiproliferative mechanism of action of cryptophycin-52: kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends.
    Panda D; DeLuca K; Williams D; Jordan MA; Wilson L
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9313-8. PubMed ID: 9689077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From racemic precursors to fully stereocontrolled products: one-pot synthesis of chiral α-amino lactones and lactams.
    You ZH; Chen YH; Liu YK
    Org Biomol Chem; 2016 Jul; 14(26):6316-27. PubMed ID: 27270561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequencing of three-component olefin metatheses: total synthesis of either (+)-gigantecin or (+)-14-deoxy-9-oxygigantecin.
    Hoye TR; Eklov BM; Jeon J; Khoroosi M
    Org Lett; 2006 Jul; 8(15):3383-6. PubMed ID: 16836411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diastereoselective, vinylogous mukaiyama aldol additions of silyloxy furans to cyclic ketones: annulation of butenolides and gamma-lactones.
    Kong K; Romo D
    Org Lett; 2006 Jul; 8(14):2909-12. PubMed ID: 16805514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antitumour activity of new muricatacin and goniofufurone analogues.
    Popsavin V; Srećo B; Krstić I; Popsavin M; Kojić V; Bogdanović G
    Eur J Med Chem; 2006 Oct; 41(10):1217-22. PubMed ID: 16891043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A practical total synthesis of hapalosin, a 12-membered cyclic depsipeptide with multidrug resistance-reversing activity, by employing improved segment coupling and macrolactonization.
    Palomo C; Oiarbide M; García JM; González A; Pazos R; Odriozola JM; Bañuelos P; Tello M; Linden A
    J Org Chem; 2004 Jun; 69(12):4126-34. PubMed ID: 15176838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New enzymatic strategies for enantiomers of lactams and amino acids].
    Forró E
    Acta Pharm Hung; 2011; 81(3):125-33. PubMed ID: 22165415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical anticancer activity of cryptophycin-8.
    Corbett TH; Valeriote FA; Demchik L; Polin L; Panchapor C; Pugh S; White K; Knight J; Jones J; Jones L; LoRusso P; Foster B; Wiegand RA; Lisow L; Golakoti T; Heltzel CE; Ogino J; Patterson GM; Moore RE
    J Exp Ther Oncol; 1996 Mar; 1(2):95-108. PubMed ID: 9414393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total synthesis of marine eicosanoid (-)-hybridalactone.
    Ota K; Sugata N; Ohshiro Y; Kawashima E; Miyaoka H
    Chemistry; 2012 Oct; 18(42):13531-7. PubMed ID: 22965557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselective total synthesis of the antitumor macrolide rhizoxin D.
    Lafontaine JA; Provencal DP; Gardelli C; Leahy JW
    J Org Chem; 2003 May; 68(11):4215-34. PubMed ID: 12762720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide.
    Harried SS; Lee CP; Yang G; Lee TI; Myles DC
    J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.